Biocryst Pharmaceuticals BCRX
NASDAQ BCRX
$8.35 +0.07 (+0.91%)
As of: Sep 30, 2026 · 1:25 PM EDT

Biocryst Pharmaceuticals Inc (BCRX) EV to EBIT (2025)

Updated

Biocryst Pharmaceuticals' (BCRX) EV to EBIT stood at 4.07 in Q4 2025, down 77.6% from the prior quarter.

Analysis

Biocryst Pharmaceuticals Inc (BCRX) EV to EBIT (2025) Analysis & Trends

Starting with Q1 2025, Biocryst Pharmaceuticals' EV to EBIT history includes 4 quarters.

  • Per Business Quant, the preceding three quarters came in at 18.20 (Q3 2025), 29.90 (Q2 2025) and 38.40 (Q1 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.07
Sep 30, 2025 18.20
Jun 30, 2025 29.90
Mar 31, 2025 38.40
API Access

Biocryst Pharmaceuticals Inc EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=BCRX&period=max&api_key=YOUR_API_KEY